Home › Research › Drug development
Cohort Profile Update: The Study of Health in Pomerania (SHIP)
Henry Völzke, Janka Schössow, Carsten Oliver Schmidt, Clemens Jürgens, Adrian Richter, André Werner, Nicole Werner, Dörte Radke et al.. International Journal of Epidemiology, 2022-02-25
Topic: Air pollution and environmental exposures
Plain-language summary
Therefore, respective software was developed in-house.8,9 Segmentation results are then analysed for potential associations with disease risks and to establish reference intervals of organ size and function.10 SHIP is also used as a basis for meta-research with a particular focus on incidental MRI findings and their effects on study participants.11,12 With its large amount of standardized data and the option to internally replicate findings from SHIP-START using data of the independent SHIP-TREND, the project offers good opportunities to apply new bioinformatical tools to mine the data and gain new insights into risk factors and pathomechanisms. Different examination methods compared with former examination waves. Different examination methods compared with former examination waves. Avoiding unnecessary changes in laboratory methods during the course of the study is crucial to ensure comparability of measurement results.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Völzke, H., Schössow, J., Schmidt, C. O., Jürgens, C., Richter, A., Werner, A., et al. (2022). Cohort Profile Update: The Study of Health in Pomerania (SHIP). International Journal of Epidemiology. https://doi.org/10.1093/ije/dyac034
Vancouver
Völzke H, Schössow J, Schmidt CO, Jürgens C, Richter A, Werner A, et al. Cohort Profile Update: The Study of Health in Pomerania (SHIP). International Journal of Epidemiology. 2022. doi:10.1093/ije/dyac034. PMID: 35348705.
BibTeX
@article{volzke2022-35348705,
author = {Völzke, Henry and Schössow, Janka and Schmidt, Carsten Oliver and Jürgens, Clemens and Richter, Adrian and Werner, André and Werner, Nicole and Radke, Dörte and others},
title = {{Cohort Profile Update: The Study of Health in Pomerania (SHIP)}},
journal = {International Journal of Epidemiology},
year = {2022},
doi = {10.1093/ije/dyac034},
pmid = {35348705},
url = {https://doi.org/10.1093/ije/dyac034}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Therefore, respective software was developed in-house.8,9 Segmentation results are then analysed for potential associations with disease risks and to establish reference intervals of organ size and function.10 SHIP is also used as a basis for meta-research with a particular focus on incidental MRI findings and their effects on study participants.11,12 With its large amount of standardized data and the option to internally replicate findings from SHIP-START using data of the independent SHIP-TREND, the project offers good opportunities to apply new bioinformatical tools to mine the data and gain new insights into risk factors and pathomechanisms.
- Different examination methods compared with former examination waves.
- Different examination methods compared with former examination waves.
- Avoiding unnecessary changes in laboratory methods during the course of the study is crucial to ensure comparability of measurement results.
New to this subject? Start with our plain-English guide: Treatments →
Study details
- Study designlongitudinal study
- Effect size68.8%; 50.1%; 76.6%
- Evidence strengthModerate
How this study scored 62/100
Published in a peer-reviewed journal, and it is a longitudinal study following the same people over time. Scored zero for sample size, studied in people and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 36 of the 58 points we could judge it on, which is 62 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (International Journal of Epidemiology) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 7 / 12 | A longitudinal study following the same people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2022 — within 6 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 35348705) |
| Free to read | 2 / 2 | Free to read |
| Points | 36 / 58 | Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 36 of the 58 points we could judge it on is 62 out of 100. |
| Total | 62 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Drug development from nearby years
Also tagged “deaths”
109 studies in the library carry the topic tag “deaths”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 109 tagged studies.